Cochrane Abstracts
Conventional occlusion versus pharmacologic penalization for amblyopia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Conventional Occlusion Versus Pharmacologic Penalization for Amblyopia." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437836/all/Conventional_occlusion_versus_pharmacologic_penalization_for_amblyopia.
Conventional occlusion versus pharmacologic penalization for amblyopia. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437836/all/Conventional_occlusion_versus_pharmacologic_penalization_for_amblyopia. Accessed March 27, 2025.
Conventional occlusion versus pharmacologic penalization for amblyopia. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437836/all/Conventional_occlusion_versus_pharmacologic_penalization_for_amblyopia
Conventional Occlusion Versus Pharmacologic Penalization for Amblyopia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437836/all/Conventional_occlusion_versus_pharmacologic_penalization_for_amblyopia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Conventional occlusion versus pharmacologic penalization for amblyopia
ID - 437836
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437836/all/Conventional_occlusion_versus_pharmacologic_penalization_for_amblyopia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
